T-cell-specific loss of AMPK-α1 accelerates growth of T cell acute lymphoblastic leukemia/lymphoma. Phenformin delays the onset and growth of lymphomas, in the presence of AMPK-α1. Here, PRKAA1 is linked to T-cell acute lymphoblastic leukemia.